These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 2849725

  • 1. Chronic treatment with naltrexone enhances morphine-stimulated dopamine neurotransmission: neurochemical and behavioral evidence.
    Bardo MT, Neisewander JL, Ennis RB.
    Neuropharmacology; 1988 Nov; 27(11):1103-9. PubMed ID: 2849725
    [Abstract] [Full Text] [Related]

  • 2. Chronic naltrexone supersensitizes the reinforcing and locomotor-activating effects of morphine.
    Bardo MT, Neisewander JL.
    Pharmacol Biochem Behav; 1987 Oct; 28(2):267-73. PubMed ID: 2825222
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Modification of morphine-induced locomotor activity by pertussis toxin: biochemical and behavioral studies in mice.
    Funada M, Suzuki T, Narita M, Misawa M, Nagase H.
    Brain Res; 1993 Aug 13; 619(1-2):163-72. PubMed ID: 8374774
    [Abstract] [Full Text] [Related]

  • 9. Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation.
    Tempel A, Gardner EL, Zukin RS.
    J Pharmacol Exp Ther; 1985 Feb 13; 232(2):439-44. PubMed ID: 2982011
    [Abstract] [Full Text] [Related]

  • 10. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats.
    Di Chiara G, Imperato A.
    J Pharmacol Exp Ther; 1988 Mar 13; 244(3):1067-80. PubMed ID: 2855239
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chronic d-amphetamine inhibits opioid receptor antagonist-induced supersensitivity.
    Duttaroy A, Billings B, Candido J, Yoburn BC.
    Eur J Pharmacol; 1992 Oct 20; 221(2-3):211-5. PubMed ID: 1330622
    [Abstract] [Full Text] [Related]

  • 15. Chronic opioid antagonist treatment: assessment of receptor upregulation.
    Yoburn BC, Sierra V, Lutfy K.
    Eur J Pharmacol; 1989 Nov 07; 170(3):193-200. PubMed ID: 2559854
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of chronic prenatal morphine treatment of mu-opioid receptor-regulated adenylate cyclase activity and neurotransmitter release in rat brain slices.
    De Vries TJ, Van Vliet BJ, Hogenboom F, Wardeh G, Van der Laan JW, Mulder AH, Schoffelmeer AN.
    Eur J Pharmacol; 1991 Oct 14; 208(2):97-104. PubMed ID: 1686867
    [Abstract] [Full Text] [Related]

  • 20. Opioid modulation of amphetamine-stimulated dopamine release and concentration in rat striatal slices.
    Kolta MG, Bardo MT.
    Pharmacol Biochem Behav; 1993 Dec 14; 46(4):819-25. PubMed ID: 8309961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.